HOWL Werewolf Therapeutics
- 1.390
- +0.040+2.96%
Werewolf Therapeutics所有资讯
Werewolf Therapeutics | 4：持股变动声明-高管 Lubman Ellen
Werewolf Therapeutics | 4：持股变动声明-高管 Trost Timothy W.
Werewolf Therapeutics | 4：持股变动声明-高管 Isaacs Randi
Werewolf Therapeutics | 4：持股变动声明-高管 Karunatilake Chulani
Werewolf Therapeutics | 4：持股变动声明-高管 HICKLIN DANIEL J
Werewolf Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-PFM Health Sciences, LP(7.8%),PFM Health Sciences GP, LLC(7.8%)等
Werewolf Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-BANK OF AMERICA CORP /DE/(4.9%)
Werewolf Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Rubric Capital Management LP(3.05%),David Rosen(3.05%)
Werewolf Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Adage Capital Management, L.P.(4.58%),Robert Atchinson(4.58%)等
Werewolf Therapeutics | 8-K：重大事件
Werewolf Therapeutics | 10-Q：2024财年三季报
Werewolf Therapeutics | 8-K：Werewolf Therapeutics公布2024年第三季度财务业绩并提供业务最新情况
Werewolf Therapeutics | S-8 POS：员工福利计划证券登记(修正)
Werewolf Therapeutics | 10-Q：2024财年二季报
Werewolf Therapeutics | 8-K：Werewolf Therapeutics公布2024年第二季度财务业绩并提供业务最新情况
Werewolf Therapeutics | 8-K：重大事件
Werewolf Therapeutics | 8-K：重大事件
Werewolf Therapeutics | 8-K：重大事件
Werewolf Therapeutics | 4：持股变动声明-董事 RA CAPITAL MANAGEMENT, L.P.
Werewolf Therapeutics | 4：持股变动声明-董事 DiRocco Derek
暂无数据